250 results

• Suboxone Lawsuit Update To Be Provided to MDL Judge During Status Conference

  November 19, 2025

  Irvin Jackson

  A federal judge will meet with lead counsel in the Suboxone litigation tomorrow to receive an update on the number of Suboxone lawsuits filed and the status of discovery.

• MDL Judge Calls for New Census of Suboxone Tooth Decay Lawsuits

  October 13, 2025

  Irvin Jackson

  A federal judge has called for a second census of Suboxone tooth decay lawsuits and will require prompt filing of census forms for claims filed from October 1 forward.

• Gabapentin Use Increasing Along With Abuse Concerns: Report

  October 9, 2025

  Michael Adams

  A new report shows the number of people prescribed gabapentin has nearly tripled in the past 15 years, fueling fears of an abuse epidemic.

• Gabapentin Prescriptions Could Be Leading to Growing Abuse Epidemic: Study

  September 17, 2025

  Michael Adams

  As gabapentin continues to be prescribed more frequently for pain, new research highlights signs of misuse, fueling fears the drug could spark another addiction crisis.

• Lawyers in Suboxone Dental Lawsuits To Meet With MDL Judge for Status Conference

  September 9, 2025

  Irvin Jackson

  Attorneys involved in Suboxone dental lawsuits meet with a federal judge today to discuss progress on collecting the records needed to hold early bellwether trials.

• Kratom Seltzer Lawsuit Claims Drinks Cause Withdrawal Symptoms Similar to Opioids

  August 12, 2025

  Michael Adams

  A class action lawsuit claims Mitra-9 kratom seltzers are addictive and cause withdrawal symptoms, accusing the company of failing to warn consumers about the products’ risks.

• Suboxone MDL Judge Issues Show Cause Order to Pharmacies Failing To Turn Over Records

  August 8, 2025

  Irvin Jackson

  Pharmacies are being ordered to turn over records regarding Suboxone lawsuit plaintiffs prescription records or face contempt charges or court sanctions.

• Long-Term Opioid Addiction, Overdose Risks Emphasized on New FDA Label Warnings

  August 7, 2025

  Michael Adams

  New FDA label warnings emphasize the risks of overdose and addiction linked to long-term opioid use, reinforcing ongoing concerns about the lack of safety data for patients with chronic pain.

• Kratom Restrictions Recommended Over Addictive Properties of Synthetic 7-OH: FDA

  July 30, 2025

  Michael Adams

  Federal regulators are urging that synthetic 7-OH, a highly addictive compound derived from kratom, be added to the federal drug schedule.

• Suboxone Injury Lawyers Reappointed to Leadership Roles in Federal MDL

  July 14, 2025

  Irvin Jackson

  A federal judge has confirmed the reappointment of more than two dozen Suboxone injury lawyers to serve in leadership positions representing plaintiffs for another year.